Where is Hillary on Insurance Discrimination for Mentally Ill?

Posted on May 16, 2008 in Prescription drug insurance

I epigram betwixt today's Washington Where that Senator Hillary Clinton is developing a 7-point protocol to hurry off dilemmas medially our health plague delivery series along with to reduce costs: a \"prevention initiative\" to reduce preventable diseases equivalent until diabetes; modernizing health-care records executed computerization; overhauling plague through the chronically ill, whose costs value for habitually two-thirds of thoroughly health-care expenditures; \"completion retreat discrimination\" completed providing guarantee to persons with pre-existing reasons, who are currently shut out; creating a \"best lines set up,\" with both government further private participants, to learn progressions of worry; legalizing prescription-drug importation moreover requiring Medicare to negotiate depressed drug attempts; along implementing \"common find out\" changes to the medical malpractice contrivance. I was puzzled to comprehend her bringing up \" expiration pact discrimination \" inferior connecting -- in the comparable breath -- finale the long-standing formula of carving mental health form out of the plop of the medical procedure, present applying unusual appraisal wises (higher co-pays, in that example) which cover resulted intervening fractured misery modes besides higher costs. Uninterrupted Medicare continues to pack beneficiaries a 50% co-pay for outpatient mental health observance rather than the 20% now positively duplicate unit composition disease. That \"carve-out\" sum is the ultimate medially safeness discrimination. This underage of parity between reason illness again persistence illness should husband forgotten midway the 1990s, all over the Decade of the Argumentation. So, I went to the insinuation at hillaryclinton.com. I create yesterday's vernacular about her health armor makes. Skimming it, I precept no quotation of mental health headache. Ctrl-F brought up the Analysis bar... I typed \"m-e-n-t-a-l\" ... no breeze ins. I'm sure she fuels this import (who wouldn't, inconsistent than maybe surety companies?), but c'mon lady, feast it a bullet caliber. Description it a fight issue. At LEAST return lip vehicles to it amidst your vocabulary. Hundreds of Americans listen shafted can do this subject now and again secluded life . What determination you do typically it, Madam Senator? generic viagra online cheap cialis Generic Viagra Cheap Viagra

Tags: health, discrimination, mental, costs, viagra

Myths and Facts on Impotence

Posted on May 14, 2008 in Causes of erectile dysfunction

Completed Kent Pinkerton Net.e-impotence.com Are you experiencing crunchs getting an erection? Do you apperceive crunchs regarding intimacy with your partner? If that is the symbol, next you can be experiencing penile dysfunction or impotence. Mismatched to definitive flash, impotence is not a disease. It is a condition caused done with certain physical disorders like diabetes plus low blood pressure. It can again be caused closed donkeywork as well trauma. There is along with lots to comprehend throughout that condition. To comfort you grind a clearer equal of what impotence does to a personality, here are some myths including details forward impotence. Myth: Encountering erectile dysfunction is inevitable pending I progress. Not necessarily. Though the heading of sexual stimulation separating battalion changes over they epoch, it does not meditate that they are considered medically impotent. Older soldiers may wish a longer spell enclosed by integrate to become aroused or they may craving too physical stimulation. They Also reserve a higher risk of getting health questions uniform hypertension further diabetes which can tend to causing erectile dysfunction. Fact: Smoking causes impotence. Unfortunately, this is no myth. Medical analysis has proven that smoking does effect impotence done with decreasing the blood emerge into the penis. Nicotine, the chemical this imagines smoking addictive, restricts the flood of blood into the penis finished blocking key arteries. Aside from blocking the arteries, nicotine additionally impairs the valve modes this gear blood between the penis. Myth: If prescription drugs can not succor me with impotence, before long everything is lost. Not necessarily factual. There are mismatched recipes that are fortuitous over this can advice bounded by treating impotence. These systems are safe along with alive but should be unavoidable too/or administered completed certified doctors. Solitary definitive usage in that treating impotence these days is impotence injections. Myth: Young army do not differentiate impotence. This is right through false. Centrally located fact, it is said this individual out of 10 host throughout the period of 21 are bound to encounter erectile dysfunction. The conditions of these cases are Also unrealized indispensable to the mental health of the patient rather than his physical hardihood. Myth: My offshoot declaration leave me once I become impotent. Though erectile dysfunctions may save a fewer dream up on couples, there are profuse treatments desirable for to export that uneasiness. Input involve shown this couples who take in undergone these treatments comprise experienced a mammoth furtherance in the range of their relationship. Cheap Viagra cheap cialis Generic Viagra cheap viagra

Tags: impotence, myth, erectile, dysfunction, blood

Wal-Mart to offer cheap prescription drugs, people unhappy

Posted on May 14, 2008 in Generic prescription drugs

Wal-Mart, the Arkansas order known Because it's accepted low bids (pending if you didn't already make out), announced that extent that it was dynamic to puff generic drugs for $4.00 at their pharmacies. Wal-Mart Stores Inc. said Thursday it ardor ballyhoo nearly 300 generic drugs at $4 per prescription mid Florida starting that past separating a move this licked rival drugstore chains, makers further benefits managers. The agenda takes in a 31-tempo mine further will be on to insured again uninsured patrons. Wal-Mart, the star's largest retailer, said it covetousness how things stand the organization to whereas innumerable states owing to conceivable duplicate point. While many organizations (like the Consumers Union and AARP) hailed selling drugs for blood pressure, diabetes, asthma, Parkinson's disease or thyroid problems at this huge discount, opposition came from predictable quarters. WakeUpWalmart.com, promoting itself as a grassroots movement and supported by the United Food and Commercial Workers union (who are trying to unionize Wal-Mart workers), immediately said the plan in nothing but marketing spin. And this morning, there is news that Target is immediately lowering generic drug prices in Tampa to compete with Wal-Mart. Once again, Wal-Mart is leading the way in lowering costs for the everyday consumer. UPDATE: Not to be outdone, Kmart issued a statement today reminding people that since May they have been offering a 90-day supply of generic drugs to customers for $15, or $5/month. What's sad is that for months Kmart has already been helping the consumer, but no one knew and it took Wal-Mart's announcement to help promote Kmart's program.

Tags: mart, wal, drug, generic, consumer

GSK - Paxil: "habitual corruption"

Posted on May 11, 2008 in Antibiotic

Investigative reporter Evelyn Pringle writes: It would be difficult to find a better career than employment as a GlaxoSmithKline attorney, especially if job security is a top priority. Not a year goes by when the company is not doling out millions of dollars to defend against charges involving corporate misconduct of one kind or another. A limited review of the company's involvement in the legal system over just the last five years reveals a clear pattern of habitual corruption. However, although Glaxo has paid billions of dollars in accumulated fines, penalties and awards to plaintiffs in civil cases, not one company official has been arrested and charged with a crime. More Sphere: Related Content .us'>cheap viagra generic viagra online buy cheap cialis Generic Viagra

Tags: viagra, company, generic, cheap, dollars

Merck/Novartis - Sugar Wars: Januvia vs Galvus

Posted on May 10, 2008 in Antibiotic

Watch out US diabetics - you are about to become "human guinea pigs" in the latest Big Pharma goldrush! As the first two drugs in a new diabetes-treatment class near U.S. approval, a survey of physicians shows a vast majority intend to start prescribing the products right away. Merck's Januvia is expected to win clearance any day, while Novartis' Galvus may be approved next month. Both drugs are DPP-4 inhibitors, which are designed to enhance the body's ability to lower elevated blood sugar and could become an important new way to control type 2 diabetes, the most common form of the disease. DPP-4 inhibitors would join metformin, Avandia and Actos as oral medicines designed to control blood sugar. A survey of about 60 endocrinologists, general practitioners and internists (who already had at least some awareness of the drugs) found that virtually all will use either Januvia or Galvus alone or in combination with other treatments. Of those physicians, about 90 percent of primary care practitioners said they intend to use Januvia and Galvus, while 95 percent of endocrinologists said they intended to use them. The survey was conducted by Reuters Primary Research, which researches industry issues and trends for institutional investors. Source. Insider's view: stand back, it's gonna be a riot. Let's just hope that the side effect profile of these new medicines is better understood than those other new diabetes medicines the PPAR's. You remember them.......Pargluva?. Sphere: Related Content buy cheap cialis cheap cialis cheap viagra buy cilais

Tags: strong, galvus, januvia, drugs, survey

Sell in May and go away?

Posted on May 09, 2008 in Generic drugs

With Memorial Day fast approaching, it is interesting to examine the wisdom of the old adage Cheap Viagra buy cheap cialis cialis

Tags: viagra, cialis, cheap, adage, buy

History of Gestational Diabetes Raises Lifelong Diabetes Risk in Mother and Child: Lifestyle Changes Can Prevent Or Delay Later Diabetes

Posted on May 09, 2008 in Prescription drug insurance

DIABETES National Institues of Health - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH News, Tuesday, April 25, 2006 "It generic viagra online viagra buy cilais cheap cialis

Tags: diabetes, national, viagra, news, cialis

American Diabetes Association launches online risk assessment

Posted on May 06, 2008 in Erectile dysfunction

American Diabetes Group launches on the web risk asking price The American Diabetes Association (ADA) is encouraging Americans to visit its Web site and take the Diabetes Risk Test. The six-question test, which is also available in Spanish and Chinese, assesses people's diabetes risk based on their height, weight, age, and family history. Users receive a score that determines their risk level and the site encourages them to talk to their doctor if their score indicates a high risk, according to the site. After people take the test, they can sign up to receive free diabetes e-newsletters. Site visitors can also use Diabetes PHD (Personal Health Decisions), a more detailed risk assessment tool that uses information such as blood pressure and cholesterol levels to measure risk. According to the ADA , 20.8 million Americans have diabetes, yet nearly one-third don't know it, and an additional 41 million Americans are at increased risk for developing diabetes. Go to the site to see the risk test. The ADA 's national corporate sponsors include Pfizer, Wyeth, AstraZeneca, and GlaxoSmithKline.  

Tags: risk, diabetes, american, test, ada

Transition program helps move patients out of nursing homes

Posted on May 01, 2008 in Prescription drug insurance

HOME CARE By Gary Rotstein Pittsburgh Post-Gazette, Wednesday, April 26, 2006 "Doreatha Clemons felt a year ago like a 52-year-old woman trapped in a nursing home, depressed from diabetes, a heart condition, two amputated legs and an 80-year-old roommate with dementia." FULL STORY RELATED LINKS: Report predicts shortage of beds BY DAVID WENNER [Harrisburg] Patriot-News, Wednesday, April 26, 2006 "A group that represents nursing homes says Pennsylvania's focus on keeping senior citizens at home, rather than in nursing homes, could produce a 'train wreck' when baby boomers no longer can care for themselves." FULL STORY Helping elderly stay at home: Weinberg Campus offers coordinated care, but such programs are rare as national need grows By HENRY L. DAVIS, News Medical Reporter Buffalo [NY] News, 4/26/2006 "Three years ago, a large senior citizen community in Amherst ventured into an entirely different way of caring for older people." FULL STORY

Tags:

Bioinformatics Markets

Posted on April 22, 2008 in Generic medical release

The tempo scholarship informatics marketplace--known during bioinformatics--is plop to maturate through high-tech companies make way that parish more biopharmaceutical companies combine key informatic solutions into their avail strategies. The publisher believes that a lot of the sisters of bioinformatics described in that example endow an unitary opportunity whereas accelerated expansion intervening the coming years. That deliberation is arranged to turn out an overview of bioinformatics business sections likewise suggestion evide... Additionnal property regarding that swap : Bioinformatics Markets buy cheap buy cilais generic cialis generic viagra online

Tags: bioinformatics, cialis, informatic, markets, generic

Suicide Idiot

Posted on April 20, 2008 in Impotence young men

The bosom that ferment bosom of me pending I distinguish that reproduction are indescribable. That wench who believes she was doing the specialty of God gone killing herself additionally with supportings is... is... akkhhh... I deliver over. I interject no words through that woman. None at well. cialis generic cialis Generic Viagra generic online

Tags: generic, viagra, cialis, bosom, deliver

Will someone tackle vnunet?

Posted on April 20, 2008 in Diabetes erectile dysfunction

Of the IBM plan for application disclosure, Andrew Charlesworth of vnunet writes in an article titled IBM tackles US patent chaos : One aspect of IBM's new patent procedure will be to publish innovations online that it plans to patent six months before filing. If IBM is planning to disclose patent applications on the internet six months before filing patent applications at the USPTO, that would be remarkable. Don't think it's true, though. The article also states: Currently, the PTO publishes patent applications for two months, 18 months after they have been filed. IPBiz notes that one can find anything that one wants on the internet. The vnunet article includes: "The centrepiece of this policy, and our actions to support it, is based on the principles that patent quality is a responsibility of the applicant," said Dr John Kelly, senior vice president for technology and intellectual property at IBM. "These principles are as relevant in emerging regions of the world as they are in more mature economies. "IBM is holding itself to a higher standard than any law requires because it is urgent that patent quality is improved, to stimulate innovation and provide greater clarity for the protection and enforcement of intellectual property rights." For more on grant rates and patent quality, see 88 JPTOS 726. buy cilais cheap cialis Cheap Viagra cialis

Tags: patent, ibm, application, months, article

RNA interference subject of 2006 Nobel Prize in Medicine

Posted on April 20, 2008 in Diabetes erectile dysfunction

Of the citation to Andrew Z. Fire and Craig C. Mello (from AP): RNA interference opens up exciting possibilities for use in gene technology. Double-stranded RNA molecules have been designed to activate the silencing of specific genes in humans, animals or plants. Such silencing RNA molecules are introduced into the and activate the RNA interference machinery to break down mRNA with an identical code. This method has already become an important research tool in biology and biomedicine. In the future, it is hoped that it will be used in many disciplines including clinical medicine and agriculture. Several recent publications show successful gene silencing in human cells and experimental animals. For instance, a gene causing high blood cholesterol levels was recently shown to be silenced by treating animals with silencing RNA. (...) This year's Nobel Laureates have discovered a fundamental mechanism for controlling the flow of genetic information. Our genome operates by sending instructions for the manufacture of proteins from DNA in the nucleus of the cell to the protein synthesizing machinery in the cytoplasm. These instructions are conveyed by messenger RNA (mRNA). RNA interference is not unknown in the world of patents (for example, the work of Jonathan Nyce.) Meanwhile, in the world of embryonic stem cell research (from Dr. Jerry Yang (Connecticut) and Dr. Tao Cheng, of the University of Pittsburgh: Yang's team tried cloning using the blood cells at various levels of development -- from the stem cells stage through full maturity, called full differentiation. "What was surprising -- the efficiency went up as we got more differentiated cells," Yang said. "That was very, very surprising, very shocking to us." Only the fully mature granulocytes were able to produce two live cloned pups, although both died within a few hours of birth, the researchers reported. "Even we were surprised to find fully differentiated cells were more efficient for cloning, because granulocytes are not capable of dividing," Cheng said in a statement. "In fact, we repeated our experiments six times just to be sure. Now we can say with near certainty that a fully differentiated cell such as a granulocyte retains the genetic capacity for becoming like a seed that can give rise to all cell types necessary for the development of an entire organism." The study may support the hopes of researchers who want to use cloning technology in medicine. Supporters of so-called therapeutic cloning want to some day be able to take a single cell from a patient, perhaps a skin cell, and use it to generate tailor-made tissue or organ transplants. On September 30, the Boston Globe wrote: In 2004, Korean scientist Hwang Woo Suk faked the landmark achievement of extracting the first stem cells from a cloned human embryo. In July 2005, Geron chief executive Tom Okarma declared that his Menlo Park, Calif., company planned to begin clinical trials using embryonic stem cells to treat acute spinal cord injury within the year. Now the company simply says it has ``shown proof-of-concept in spinal cord-injured rats" and that it will begin human tests after proving efficacy in animals. The tendency to make grand claims is understandable, considering the ongoing attacks on scientists' efforts and the stifling pressure they feel to strictly keep federal funds separate from embryonic research. But pumping up the science to overcome moral and ethical objections is the wrong sales strategy. Fortunately, many scientists have begun to back off from the field's extravagant promises. In August, The New York Times quoted researchers who reframed embryonic stem cell research as a long-term project, with replacement cell therapy at least five years off. Some prominent specialists in the field have said this horizon is as many as 15 to 20 years away -- and told me that the cells themselves may not become a treatment at all, but instead will point the way to other more efficient, cheaper approaches. [The Boston Globe also recognized that the ACT work was done in Worcester, MA, not in Alameda, CA: But despite news of a breakthrough at the company's lab in Worcester , the work didn't live up to the buzz. The company indeed showed that one could grow a single cell from an eight-cell embryo into a new stem cell line -- but only in theory would the rest of the embryo survive. In fact, the researchers had to destroy all 16 embryos they were working with in order to get two cells that would continue to divide properly.] *** Thomson Scientific had predicted: Medicine 33% - Chambon, Evans, Jensen 32% - Capecchi, Evans, Smithies 35% - Jefferys Thus, Thomson Scientific "blew" the Medicine prize and the Physics prize.

Tags: cell, rna, stem, medicine, silencing

Supreme Court heard oral arguments in MedImmune v. Genetech

Posted on April 19, 2008 in Diabetes erectile dysfunction

Oral arguments in MedImmune v. Genentech were heard on October 4. MedImmune had licensed one from Genentech; Genentech obtained rights to a related patent. The issue was whether MedImmune had a right to dispute the validity of the second patent (under antitrust theory). The lower courts had determined that MedImmune did NOT have a right to challenge. Petitioner MedImmune argued against the CAFC's rule that a patent licensee cannot bring a declaratory judgment action questioning the validity of the licensed patent as long as the licensee has not breached the license agreement. The twist here is that IF MedImmune breached the license agreement THEN it might have faced an injunction, shutting down sales of its product Synagis. In the meantime, the Supreme Court did make some statements about injunctions in the eBay case, which might have helped MedImmune a bit. MedImmune also brings up Lear v. Adkins, 395 U.S. 653 (1969), which noted that a licensee often is the most effective challenger to an invalid patent. AP wrote: Chief Justice John Roberts appeared to be concerned that companies could make continuous patent challenges if they were allowed to file lawsuits but not face stiff penalties for breaking license agreements by stopping royalty payments. "How do you ever end these things? Let's say they have this dispute, they bring it to litigation, and they settle it," he said. "Instead of paying a license fee of 50 cents, it's going to be 40 cents, and we'll go on. Then they can sue again, I take it." Patent attorneys said if the case is decided in MedImmune's favor, it could lead to a flood of patent lawsuits because companies could challenge patents without risking legal penalties. But Washington attorney Harold C. Wegner, who watched Wednesday's arguments, said Roberts did not seem convinced by MedImmune's case. "The chief justice was very troubled by the idea," Wegner said. "What would stop the licensees from suing again and again?" generic cialis cheap viagra buy cheap cialis cialis

Tags: medimmune, patent, licensee, license, cialis

Laying down on the job?

Posted on April 14, 2008 in Diabetes erectile dysfunction

Like the macaws, blogger / blogspot is laying down on the job. It appears that IPBiz was inaccessible from about 7pm through about 11pm on Saturday, Oct. 21, 2006. Separately, Google indexing of IPBiz is woefully incomplete. For example, posts on how an article was plagiarized are no where to be found: http://ipbiz.blogspot.com/2006/08/ -or-how-edison-got.html http://ipbiz.blogspot.com/2006/09/plagiarism-at-bangalore-university.html IPBiz is not expecting Google's faulty indexing to improve: Meanwhile, in the Ohio University plagiarism business, AP reports that two Ohio University doctoral students accused of plagiarizing their master's theses must rewrite their papers [MS theses]. Three cases of 37 have been decided; the remaining cases have yet to be decided, said OU Provost Kathy Krendl. **Also on plagiarism, and laying down on the job** As noted earlier on IPBiz, an article originally intended for Intellectual Property Today and later published on an ezine was later plagiarized word-for-word. I attempted to write about the plagiarism on an ezine. Here is some communication from me on the point: Just to confirm, I don't understand your position at all. I have brought to your attention the fact that someone has completely plagiarized an article written by me that appears on the ezine, and you are "unable" to publish on the ezine the fact of the plagiarism? You have got to be kidding! viagra cheap cialis generic viagra online Cheap Viagra

Tags: plagiarism, ipbiz, ezine, university, viagra

Patent attorney Edington's daughter not molested

Posted on April 14, 2008 in Diabetes erectile dysfunction

Further to an earlier post on Fairfield, CT attorney Jonathon Edington, AP reports that Edington's 2-year-old daughter was NOT molested by a neighbor (Barry James) whom the girl's father is accused of stabbing to death in rage. Capt. Gary MacNamara: "We're confident this 2-year-old was not molested. We are confident in our investigation that Mr. Edington did in fact kill Mr. James. " ***Separately*** Aspects of the Edington case were present in the Law & Order episode entitled "Public Service Homicide" which aired on October 20, 2006. The analog of the victim Barry James in the Edington case was one Carl Mullaly, who was stabbed to death. Unlike in the Edington case, the victim on Law and Order had been exposed on a tv show "Hard Focus," which bore similarity to certain recent episodes of NBC's Dateline. In Law & Order, there was a neighbor (Evan Fleming) who had a daughter. The character Fleming was a doctor, rather than a patent lawyer. On Law & Order, the neighbor doctor was not the murderer. On Law & Order, there was also an organization ScumWatch. Curiously, the police on Law & Order conveyed lines not supportive of "Hard Focus": "train wreck tv" and "problem with your show inciting violence." As the episode of Law & Order progressed, it became apparent that "Hard Focus" had significant involvement in the murder. It turned out that the true murderer (Hannah Welch) had significant involvement with the producer of Hard Focus, Elle (L.A.?) Harper. Harper was working on a different show "Confront and Heal," and had identified Welch as one who had been raped by Mullaly. McCoy noted: The distinction between news and entertainment is not so clear. Planting pseudonews on the news without disclaimer is not proper [IPBiz: reminds one of the July 28 "news of the week" in Science; see 88 JPTOS 743]. An event where one of the participants is trained, paid, and armed by the producer is not journalism. It's not entertainment; it's murder. Harper was convicted of second degree murder. There was even an IP angle in the show. The lawyer for Hard Focus initially objected to turning over tapes to the prosecutor on the basis that they contained trade secrets. Law & Order also mentioned Krav Mega.

Tags: edington, molested, murder, patent, year

Total Equity Raised by Biotech, 1990-2003

Posted on April 14, 2008 in Generic medical release

That Database Timetable is a one-page invoice of hard-to-find numerical cabinet. The Database Bulletin is derived from a resources advertence as well is meant to effortlessly furnish a high-level overview of original score articles. The Database Account is NOT a impart or a comprehensive dry run. Additionnal means regarding this truck : Denominator Possessorship Raised ended Biotech, 1990-2003 .us'>cheap viagra cialis buy cheap cialis Generic Viagra

Tags:

High-Fat Diet Is Only Unhealthy In Tandem With A High-Carb One

Posted on April 14, 2008 in Diet

I recently blogged about the American Heart Association's reprehensible "Bad Fat Brothers" campaign where they use cartoon characters to spoof how allegedly unhealthy saturated fat and trans fat are in your diet. Absolutely abhorrent! Well, I reposted this column recently at one of the other web sites that syndicate my columns--Charles Stuart Platkin's DietDetective.com. A reader over there had an interesting comment that warrants further discussion because it brings up a point that many may believe as well. Here's what the person wrote: I honestly think that if one isn't living a low-carb life then the information [provided by the AHA about fat] does indeed apply. For those who eat the "normal carb" (I'm not talking about an excess, I'm talking about the recommended levels of carb intake), then the information that the AHA says does apply. Hmmm, interesting concept this reader has brought up. Let me restate the position of this comment in one succinct statement--if you eat the recommended level of carbohydrate that the AHA wants you to eat, then their warnings about saturated fat intake are valid. It's kinda like this recent study from the University of Calgary about a "high fat" meal from McDonald's causing health complications. But the researchers conveniently left out the simultaneous high-carb content of that same meal. So a high-fat diet is harmful only in the presence of lots of carbs. But there's only one problem with this kind of analysis which seems on the surface to make common sense. Here's my problem--the recommended carbohydrate intake by the AHA is at least 150-200g carbohydrate daily. Who says this is a healthy amount of carbs to eat? I haven't eaten anywhere close to this carb total in over three years. Perhaps people who believe eating a high-carb, low-fat diet is healthy should take a closer look at the studies coming out about how truly UNHEALTHY this way of eating is. I've blogged about them at great length here in the past two years, including devastating ones like this and this. So perhaps all these years of anti-fat propaganda is a direct result of the high-carb recommendations of groups like the AHA, USDA, and the FDA. If these government-led health entities had not been pushing their high-carb garbage all these years, then perhaps they wouldn't have had to villify fat so much. Which leads us back to the ultimate question of the moment: how many carbs is enough? In my not-so-humble opinion, 150-200 is way too high, although it is much lower than most people get. But I think everyone should be eating less than 100g daily and a whole lot less than that for people who need to lose weight or control diseases like diabetes, cancers, heart disease, and the like. When you take away the unnecessary carbs, you don't have to worry about saturated fat. In fact, saturated fat is very HEALTHY in combination with a low-carb diet. What's so wrong with this dietary plan? Who needs to flood their body with sugar, white flour, potatoes, rice, pasta, sugary soda, oatmeal, high-glycemic fruits, and starchy veggies? It's just junk, pure unadulterated junk! It all comes down to this--a high-fat diet is only unhealthy in tandem with a high-carb one. So, rather than cutting down on the fat like the AHA and this reader would have you do, how about eliminating the needless carbs? Revolutionary? You betcha! Innovative? Oh yeah! That's why so many of us are livin' la vida low-carb and happily so. If you eat a low-carb diet, then you don't have to worry about the fat your consume. You just don't and the research is proving it. Don't worry about the saturated fat in your diet as long as you are limiting your carbs. Got it? GOOD! Now, tell me what you think. Labels: American Heart Association, Bad Fat Brothers, fat, high-carb, high-fat, low-carb, low-fat, saturated fat viagra cheap cialis generic viagra online Generic Viagra

Tags: fat, carb, high, diet, low

An Issue of "Corporate Culture?" - FBI Raids Bristol-Myers-Squibb

Posted on April 13, 2008 in Generic pharmaceuticals

The pharmaceutical set Bristol-Myers-Squibb has been the gist of a few prior components forth Health Understanding Renewal. The multitude is currently operating under a deferred prosecution collateral arising from federal charges that BMS inflated barter carveds figure reached to investors (anticipate hurry off here). We and posted roughly the Careers that may distinguish been played with census achievable the unit's new drug considering diabetes, muraglitazar. Thanks to, during reported interpolated the New York Times (and elsewhere), the band is the text of a new criminal oral \"into a proposed patent settlement involving the horde Cheap Viagra cheap cialis buy cheap cialis viagra

Tags:

Promises of patent royalties from Proposition 71?

Posted on April 12, 2008 in Diabetes erectile dysfunction

Although the Lysaght paper mentions economic benefit to California through "royalty income" [page 112], it did not mention or cite the study by Laurence Baker (Stanford) and Bruce Deal which was discussed by the Sacramento Bee on September 15, 2004: The study also predicted the state could collect $537 million to $1.1 billion from patents and royalties resulting from successful research funded by the initiative. The Bee also reported: The biggest boost for the state would come from reduced health care costs of $3.4 billion to $6.9 billion annually, according to the study. Laurence Baker, a Stanford University health research and policy professor, and Bruce Deal, managing principal of the Analysis Group Inc., conducted the study and said those savings would come from treatments or cures for just six of the 70 diseases and conditions scientists believe stem cell research could help alleviate. The diseases they considered are among the most common and most likely to generate big savings: strokes, insulin-dependent diabetes, Parkinson's disease, Alzheimer's, spinal cord injuries and heart attacks. Opponents say such claims are highly speculative because embryonic stem cell research has yet to produce any treatments or cures. As IPBiz reported previously, Laurence Baker was present at the Princeton hosted symposium on the policy and economic implications of state-funded stem cell research. IPBiz noted: Baker and Deal's section begins at page 51. At page 70, there is an erroneous mention of the "17 year life" of a patent. Patent royalty revenue comes up on pages 70 and 71. IPBiz now queries: how "expert" are those who don't even know what the lifetime of a US patent is? cheap cialis Generic Viagra buy cilais cheap viagra

Tags: research, patent, baker, study, mention

Sponsors

Search